U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541261) titled 'A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia' on April 14.
Brief Summary: The main purpose of this study is to evaluate treatment persistence of guselkumab (that is how long a person keeps taking their prescribed medicine or continues with their treatment plan without stopping) in participants with moderate to severe crohn's disease (CD) or ulcerative colitis (UC) in real-world setting. CD and UC are Inflammatory bowel disease, a group of inflammatory conditions of the colon and small intestine.
Study Start Date: April 17
Study Type: OBSERVATIONAL
Condition:
Colitis
Ulcerative
Crohn...